Literature DB >> 25701342

Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.

Rui Zhang1, Gui-zhen He2, Yu-kang Wang1, Kai-guo Zhou1, En-ling Ma1.   

Abstract

OBJECTIVE: To investigate the active factors and the intervention effect of ω-3 polyunsaturated fatty acids (PUFAs) during intestinal ischemia-reperfusion (I/R) injury, which causes the inflammation of monocytes-macrophages cultured in lymph fluid and stimulated with ω-3 PUFAs.
METHODS: Forty-eight Sprague-Dawley male rats were randomly divided into the following two groups: A. (N + D) group and B. (I/R + D) group. The rats in the (N + D) group were drained of lymph for 180 min; the rats in the (I/R + D) group were subjected to 60 min ischemia by clamping the superior mesenteric artery followed by 120 min reperfusion and 180 min of lymph draining. Lymph fluid from each group was further divided into 4 subgroups, respectively: lymph group (A1, B1); eicosopentaenoic acid (EPA)-treated group (A2, B2); EPA + docosahexaeonic acid (DHA)-treated group (A3, B3); and DHA-treated group (A4, B4), then cultured monocyte-macrophage cell line.
RESULTS: The levels of tumor necrosis factor-α, interleukin (IL)-1 β, IL-6, soluble cell adhesion molecule-1, chemotactic factors macrophage chemoattractant protein-1, macrophage inflammatory protein-2, and high mobility group box protein 1 in the B1 group were significantly higher than in the A1 group. Importantly, addition of EPA, EPA + DHA, and DHA to the culture media significantly reduced the levels of the above-mentioned factors. Cell stimulation with EPA, EPA + DHA, and DHA also significantly decreased the expression of Toll-like receptor 4, nuclear factor-κB p65, macrophage chemoattractant protein-1, and macrophage inflammatory protein-2 with the combined treatment of EPA and DHA showing the strongest effect.
CONCLUSIONS: The factors induced in lymph during intestinal I/R injury can cause inflammation in vitro. These data provide in vitro evidence that ω-3 PUFAs provide a protective effect by reducing the inflammatory response caused by intestinal I/R lymph. Moreover, the synergism of EPA and DHA had the greatest effect, which is possibly mediated through Toll-like receptor 4 and nuclear factor-κB p65.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DHA; EPA; Intestinal lymph drainage; Ischemia reperfusion; NF-κB p65

Mesh:

Substances:

Year:  2014        PMID: 25701342     DOI: 10.1016/j.nut.2014.10.015

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

Review 1.  Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.

Authors:  Dominique L Doster; Amanda R Jensen; Sina Khaneki; Troy A Markel
Journal:  Cytotherapy       Date:  2016-10-10       Impact factor: 5.414

2.  In vitro effect of flaxseed oil and α-linolenic acid against the toxicity of lipopolysaccharide (LPS) to human umbilical vein endothelial cells.

Authors:  Yuexin Shen; Gui Chen; Aiping Xiao; Yixi Xie; Liangliang Liu; Yi Cao
Journal:  Inflammopharmacology       Date:  2017-09-22       Impact factor: 4.473

3.  Enteral nutrition ameliorates the symptoms of Crohn's disease in mice via activating special pro-resolving mediators through innate lymphoid cells.

Authors:  Di Zhao; Bo Yang; Chen Ye; Shaoyi Zhang; Xiaoqiong Lv; Qiyi Chen
Journal:  Innate Immun       Date:  2021-11-18       Impact factor: 2.680

4.  Chronic Psychological Stress Was Not Ameliorated by Omega-3 Eicosapentaenoic Acid (EPA).

Authors:  Joanne Bradbury; Stephen P Myers; Barbara Meyer; Lyndon Brooks; Jonathan Peake; Andrew J Sinclair; Con Stough
Journal:  Front Pharmacol       Date:  2017-10-31       Impact factor: 5.810

5.  Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats.

Authors:  Alexandra Boivin; Mélanie Burban; Raphaël Clere-Jehl; Pierrick Le Borgne; Hamid Merdji; Cyril Auger; Valérie Schini-Kerth; Ferhat Meziani; Julie Helms
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

6.  The effect of n-3/n-6 polyunsaturated fatty acids on acute reflux esophagitis in rats.

Authors:  Ze-Hao Zhuang; Jing-Jing Xie; Jing-Jing Wei; Du-Peng Tang; Li-Yong Yang
Journal:  Lipids Health Dis       Date:  2016-10-04       Impact factor: 3.876

Review 7.  Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.

Authors:  Hajar Mazahery; Welma Stonehouse; Maryam Delshad; Marlena C Kruger; Cathryn A Conlon; Kathryn L Beck; Pamela R von Hurst
Journal:  Nutrients       Date:  2017-02-19       Impact factor: 5.717

8.  Association between serum n-3 polyunsaturated fatty acids and quadriceps weakness immediately after total knee arthroplasty.

Authors:  Yusuke Kubo; Shuhei Sugiyama; Rie Takachu; Maki Tanaka; Masae Ikeya; Takeshi Sugiura; Kaori Kobori; Makoto Kobori
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

9.  Pretreatment with Fish Oil-Based Lipid Emulsion Modulates Muscle Leukocyte Chemotaxis in Murine Model of Sublethal Lower Limb Ischemia.

Authors:  Yao-Ming Shih; Juey-Ming Shih; Yu-Chen Hou; Chiu-Li Yeh; Cheng-Che Li; Sung-Ling Yeh
Journal:  Mediators Inflamm       Date:  2017-01-15       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.